1. Home
  2. HCTI vs LNAI Comparison

HCTI vs LNAI Comparison

Compare HCTI & LNAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

HCTI

Healthcare Triangle Inc.

N/A

Current Price

$0.69

Market Cap

11.4M

Sector

Technology

ML Signal

N/A

Logo Lunai Bioworks Inc.

LNAI

Lunai Bioworks Inc.

N/A

Current Price

$1.42

Market Cap

12.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
HCTI
LNAI
Founded
2020
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Retail: Computer Software & Peripheral Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
11.4M
12.4M
IPO Year
2021
2014

Fundamental Metrics

Financial Performance
Metric
HCTI
LNAI
Price
$0.69
$1.42
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 2.6M
36.4K
Earning Date
11-12-2026
11-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
N/A
★ N/A
Revenue
★ $13,891,000.00
N/A
Revenue This Year
$179.58
N/A
Revenue Next Year
$4.39
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
★ 18.77
N/A
52 Week Low
$0.14
$0.15
52 Week High
$9.97
$5.02

Technical Indicators

Market Signals
Indicator
HCTI
LNAI
Relative Strength Index (RSI) 39.88 25.99
Support Level $0.65 $0.26
Resistance Level $1.01 $2.58
Average True Range (ATR) 0.23 0.25
MACD 0.01 -0.08
Stochastic Oscillator 1.79 7.39

Price Performance

Historical Comparison
HCTI
LNAI

About HCTI Healthcare Triangle Inc.

Healthcare Triangle Inc is a healthcare information technology company focused on advancing industry-transforming solutions in the sectors of cloud services, data science, and professional and managed services for the healthcare and life sciences industry. The company reinforces healthcare progress through technology and extensive industry know-how. HTI supports healthcare providers and payors, hospitals, and Pharma Life Sciences organizations in their efforts to improve health outcomes by enabling the adoption of new technologies, data enlightenment, business agility, and accelerated response to immediate business needs and competitive threats. It provides services under three operating segments: Software Services, Managed Services, and Support and Corporate & others.

About LNAI Lunai Bioworks Inc.

Lunai Bioworks Inc is a biopharmaceutical company. Through its subsidiaries, it is mainly focused on developing allogeneic cell and gene therapies to promote stronger immune system responses, potentially for long-term or life-long cancer remission in some of the deadliest cancers. The group is engaged in the development of RENB-DC11 and RENB-DC20 (potential cell therapeutic vaccine candidates for different types of cancer); a proprietary AI platform that analyzes genetics to provide earlier and more accurate cancer diagnosis; and machine learning pipelines that harmonize and analyze complex, heterogeneous datasets to uncover clinically actionable insights. The group's reportable segments are: RENB, BioSymetrics, and RENC. Geographically, it operates in the United States and Netherlands.

Share on Social Networks: